Motor Neurone Disease Trial, Recruiting NCT06390930 Sponsor: Shirley Ryan AbilityLab Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT06390930
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who were diagnosed with relapsing-remitting multiple sclerosis (a type of MS with flare-ups and periods of recovery) more than 5 years ago, based on specific diagnostic guidelines called the McDonald criteria
  • People who have not had an MS relapse (flare-up) for at least 6 months
  • People whose MS-related disability falls within a certain range on a standard disability measurement scale (EDSS score of 7 or below)
  • People who have reduced strength or dexterity in at least one hand, as measured by specific clinical tests (confirm with trial site for exact testing details)
  • People whose MS medications have remained unchanged for at least 6 months
  • People taking a medication called dalfampridine, provided the dose has stayed the same for at least 2 months before the screening visit

Who may not be able to join:

  • People who have another condition — such as a nerve or bone/joint problem — that also affects how their arms or hands work
  • People who score below 24 on a standard memory and thinking assessment called the Mini-Mental State Examination
  • People who have significant muscle stiffness in the elbow joint, above a certain level on a standard clinical scale
  • People with blood pressure that is not well controlled — either too high (above 140/90 mmHg) or too low (below 85/55 mmHg)
  • People with a history of epilepsy, chronic obstructive pulmonary disease (a lung condition), or sleep apnea
  • People with unstable health conditions, those currently receiving therapy for their arms or hands, or those experiencing ongoing pain in muscles or joints
  • People who are pregnant, as confirmed by a urine test

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Milap Sandhu, Shirley Ryan Ability Lab

Phone: 3122383947

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shirley Ryan AbilityLab
Registry
ClinicalTrials.gov
Start date
1 February 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Motor Evoked Potentials (MEPs) in First Dorsal Interosseous (FDI); Changes in Spinal Reflex Threshold; Threshold For Detecting Passive Joint Movement; Accuracy of Direction Estimation of Passive Joint Movement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov